Mefloquine
مفلوکین
🐛 Antiparasitic Products, Insecticides And RepellentsAntimalarial
Market / country: 🇺🇸 USA
Lariam (US)
🧮 Dose calculator
Malaria (prophylaxis and treatment) · Regimen source: FDA Mefloquine · Dosage and Administration
- • With food and at least 240 mL water. In P. vivax follow with primaquine to prevent relapse. FDA Mefloquine · Dosage and Administration
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to mefloquine or related compounds (quinine, quinidine). FDA Mefloquine · Contraindications
- ⛔ Not for prophylaxis with active or recent depression, generalised anxiety, psychosis, schizophrenia or other major psychiatric disorder, or a history of seizures. FDA Mefloquine · Contraindications
Warnings
- • Boxed warning: neuropsychiatric adverse reactions that can persist after stopping; stop and substitute if symptoms occur. FDA Mefloquine · Boxed Warning
Formulations
- 250 mg tablet (scored) — tablet 🇺🇸 USA FDA Mefloquine · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Mefloquine · Pregnancy
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Mefloquine · Nursing Mothers
“Caution should be exercised when administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Mefloquine · Pediatric Use
“The safety and effectiveness of mefloquine for the treatment of malaria in pediatric patients below the age of 6 months have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Mefloquine · Geriatric Use
“Since electrocardiographic abnormalities have been observed in individuals treated with mefloquine (see PRECAUTIONS ) and underlying cardiac disease is more prevalent in elderly than in younger patients, the benefits of mefloquine therapy should be weighed against the possibility of adverse cardiac effects in elderly …”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA076392
- DailyMed (FDA label)FDA Mefloquine
- MedlinePlus (NIH)Mefloquine
- WHO ATC/DDDP01BC02
- Darooyab (Iran)Mefloquine
🇮🇷 Registered in Iran Darooyab · G-843/Mefloquine
Dosage forms with Iranian generic codes, per Darooyab.
- 00796 · MEFLOQUINE 250MG TAB · قرص مفلوکوین ۲۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Mefloquine · How SuppliedFDA Mefloquine · Dosage and AdministrationFDA Mefloquine · ContraindicationsFDA Mefloquine · Boxed WarningFDA Mefloquine · PregnancyFDA Mefloquine · Nursing MothersFDA Mefloquine · Pediatric UseFDA Mefloquine · Geriatric UseFDA Mefloquine · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-843/Mefloquine
- Clinical review⚠ Unverified